The Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland 21287
2 studies enrolling now · 16 studies all time
What they study most
Acupressure, Acute Lymphoblastic Leukemia, Adenocarcinoma, Advanced Cancer, Various, NOS, Advanced Non-Small Cell Lung Cancer, Bone Marrow Failure Syndromes, Cancer, Cancer-related Problem/Condition, Diabetes, Exercise, HIV, Hepatocellular Carcinoma
Studies at this site
- Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
- A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma — Recruiting now
- Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis — Running, not enrolling
- An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma — Completed
- Tailored Home-Based Exercise Program for Multiple Chronic Conditions — Completed
- Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer Survivors — Completed
- Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia — Completed
- Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Individuals — Completed
- A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma — Stopped early
- A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia — Completed
- Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma — Completed
- A Phase I Open Label Study of the Safety and Tolerability of Elotuzumab (BMS-901608) Administered in Combination With Either Lirilumab (BMS-986015) or Urelumab (BMS-663513) in Subjects With Multiple Myeloma — Completed
- Bone Marrow Transplant Trial for Patients With Refractory Severe Aplastic Anemia — Stopped early
- Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma — Completed
- A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer — Completed
- ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer — Completed